PF587 SELINEXOR, POMALIDOMIDE, AND DEXAMETHASONE (SPD) IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

Authors :: M. Sebag
M. Kauffman
G. Schiller
N. Callander
B. Lipe
S. Lentzsch
W. Bensinger
S. Tuchman
C. Gasparetto
K. Rodriguez-Lopez
H. Sheehan
R. LeBlanc
D. White
S. Shacham
C. Venner
Jean-Richard Saint-Martin
H. Sutherland
J. Shah
Nizar J. Bahlis
Christine Chen
M. Baljevic
R. Kotb
Source :: HemaSphere. 3:245
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
medicine
Refractory Multiple Myeloma
In patient
Hematology
Pomalidomide
business
Dexamethasone
medicine.drug

Full Text Access

Tools